{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-033364","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2026-07-15T20:18:23+00:00","discovered_at":"2026-07-15T20:19:00.437390+00:00","generated_at":"2026-07-15T20:19:11.065154+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Regen Biopharma settles $398,740 claims via share issuance; creates Series N preferred with 75M votes per share","bullets":["Court approved settlement with Trillium Partners: Regen will issue shares (common or Series A preferred) to satisfy $398,740 in claims; shares sold by plaintiff, 65% of net proceeds to plaintiff.","Potential dilution: number of shares indeterminable; as of April 17, 2026, common shares outstanding ~402.9M; CEO David Koos is a creditor and will be paid after one year.","Created Series N Preferred Stock: 1,000 shares authorized, each with 75 million votes, enabling concentrated voting control.","Changed auditor: BCRG replaced by Simon & Edward LLP after acquisition; no disagreements, but prior reports had going concern qualification."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-033364","json":"https://secwatch.observer/filing/0001493152-26-033364.json","markdown":"https://secwatch.observer/filing/0001493152-26-033364.md","text":"https://secwatch.observer/filing/0001493152-26-033364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000149315226033364/0001493152-26-033364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000149315226033364/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-15T20:19:11.065154+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}